Epidermal cytokines in murine cutaneous irritant responses

Journal of Applied Toxicology

Volumn 20, Issue 4, 2000, Pages 335-341

  Effendy, Isaak ^a   Löffler, Harald ^a   Maibach, Howard I ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contact hypersensitivity; Irritant contact dermatitis; Skin irritation; Skin stripping; UV radiation

Indexed keywords

CYTOKINE;

ALLERGIC REACTION; ARTICLE; CELL CULTURE; CONTACT ALLERGY; EPIDERMIS; IMMUNOLOGY; IN VITRO STUDY; IN VIVO STUDY; IRRITANT DERMATITIS; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN IRRITATION;

ANIMALS; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; EPIDERMIS; IRRITANTS; KERATINOCYTES; MICE; UP-REGULATION;

MURINAE;

EID: 0343457968     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1263(200007/08)20:4<335::AID-JAT698>3.0.CO;2-L     Document Type: Article

References (79)

1. Bason M, Lammintausta K, Maibach HI. Irritant dermatitis (irritation). In Dermatotoxicology (4th edn), Marzulli FN, Maibach HI (eds). Hemisphere: New York, 1991; 223-254.
2. Willis CM, Stephens CJ, Wilkinson JD. Differential effects of structurally unrelated chemical irritants on the density of proliferating keratinocytes in 48 h patch test reactions. J. Invest. Dermatol. 1992; 99: 449-453.
3. Patrick E, Burkhalter A, Maibach HI. Recent investigations of mechanisms of chemically induced skin irritation in laboratory mice. J. Invest. Dermatol. 1987; 88: 24s-31s.
4. Wilmer JL, Burleson FG, Kayama F, Kanno J, Luster MI. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J. Invest. Dermatol. 1994; 102: 915-922.
5. Pinkus H. Examination of epidermis by the strip method. II. Biometric data on regeneration of the human epidermis. J. Invest. Dermatol. 1951; 19: 431-447.
6. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 1994; 30: 5-546.
7. Kimber I. Cytokines and regulation of allergic sensitization to chemicals. Toxicology 1994; 93: 1-11.
8. Hoefakker S, Caubo SM, van 't Erve EH, Roggeveen MJ, Boersma WJ, van Joost T, Notten WR, Claassen E. In vivo cytokines profiles in allergic and irritant contact dermatitis. Contact Dermatit. 1995; 32: 258-266.
9. Gerberick GF, Sikorski EE, Ryan CA, Limardi LC. Use of cytokines in dermatotoxicology. In Dermatotoxicology Methods: the Laboratory Workers's Vade Mecum, Marzulli FN, Maibach HI (eds). Taylor & Francis: New York, 1998; 187-206.
10. Oppenheim JJ, Ruscotti FW, Faftynek C. Cytokines. In Basic and Clinical Immunology, Stites DP, Terr AL (eds). Prentice-Hall: Norwalk, 1991, 78-100.
11. Aggarwal BB, Puri KJ. Common and uncommon features of cytokines and cytokine receptors: an overview. In Human Cytokines: their Role in Disease and Therapy, Aggarwal BB, Puri KJ (eds). Blackwell: Oxford, 1995; 1-24.
12. Luger TA. Epidermal cytokines. Acta. Dermatol. Venereol. Stockh. 1989; 151: 61-76.
13. McKenzie RC, Sauder DN. The role of keratinocyte cytokines in inflammation and immunity. J. Invest. Dermatol. 1990; 95: 105s-107s.
14. DeLeo VA, Harbor LC, Kong BM, De Solve SJ. Surfactant-induced alteration of arachidonic acid metabolism of mammalian cells in culture. Proc. Soc. Exp. Biol. Med. 1987; 184: 477-482.
15. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet 1991a; 337: 211-214.
16. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989; 7: 145-173.
17. Allen JE, Maizels RM. Th1-Th2: reliable paradigm or dangerous dogma? Immunol. Today 1997; 18: 387-392.
18. Werfel T, Hentschel M, Renz H, Kapp A. Analysis of the phenotype and cytokine pattern of blood- and skin-derived nickel specific T cells in allergic contact dermatitis. Int. Arch. Allerg. Immunol. 1997; 113: 384-386.
19. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 1998; 19: 37-44.
20. Agarwal S, Viola JP, Rao A. Chromatin-based regulatory mechanisms governing cytokine gene transcription. J. Allerg. Clin. Immunol. 1999; 103: 990-999.
21. Kupper TS. Role of epidermal cytokines. In Immunophysiology: the Role of Cells and Cytokines in Immunity and Inflammation, Oppenheim JJ, Shevach EM (eds). Oxford University Press: New York, 1990; 285-305.
22. Ansel JC, Perry P, Brown J, Damm D, Phan T, Hart C, Luger TA, Hefeneider C. Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 1990; 94: 101s-107s.
23. Schwarz T, Luger TA. Pharmacology of cytokines in the skin. In Pharmacology of the Skin, Mukhtar H (ed.). CRC Press: Boca Raton, 1992; 283-313.
24. Lisby S, Muller KM, Jongkeneel CV, Saurat JH, Hauser C. Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Int. Immunol. 1995; 7: 343-352.
25. Shivji GM, Gupta AK, Sauder DN. Role of cytokines in irritant contact dermatitis. In Vitro Skin Toxicology: Irritation, Phototoxicity and Sensitization, Rougier A, Goldberg AM, Maibach HI (eds). Liebert: New York, 1994; 13-22.
26. Whittle E, Carter J, Wolfreys A, Basketter DA. HaCaT-derived cytokine response to noxious agents. J. Invest. Dermatol. 1995; 104: 562.
27. Mohamadzadeh M, Müller M, Hültsch T, Enk A, Saloga J, Knop J. Enhanced expression of IL-8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers, tolerogens and irritants. Exp. Dermatol. 1994; 3: 298-303.
28. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 1992; 89: 1398-1402.
29. Haas J, Lipkow T, Mohamadzadeh M, Kolde G, Knop J. Induction of inflammatory cytokines in murine keratinocytes upon in vivo stimulation with contact sensitizers and tolerizing analogues. Exp. Dermatol. 1992; 1: 76-83.
30. Kondo S, Pastore S, Shivji GM, McKenzie RC, Sauder DN. Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymph. Cytok. Res. 1994b; 13: 367-375.
31. Matsue H, Cruz Jr PD, Bergstrasser PR, Takashima A. Langerhans calls are the major source of mRNA for IL-1 beta and MIP-1 alpha among unstimulated mouse epidermal cells. J. Invest. Dermatol. 1992; 99: 537-541.
32. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. Immunol. 1993; 150: 3698-3704.
33. Rambukkana A, Pistor FHM, Kapsenberg ML, Das PK, Bos J. Role of cytokines in allergen-induced effect on human Langerhans cells. Exp. Dermatol. 1994; 3: 140.
34. Dearman RJ, Kimber I. Cytokine production and the local lymph node assay. In In Vitro Skin Toxicology. Irritation, Phototoxicity and Sensitization, Rougier A, Goldberg AM, Maibach HI (eds). Liebert: New York, 1994; 367-372.
35. Dearman RJ, Hope JC, Hopkins SJ, Debicki RJ, Kimber I. Interleukin 6 (IL-6) production by lymph node cells: an alternative endpoint for the local lymph node essay. Toxicol. Meth. 1993; 3: 268-278.
36. Dearman RJ, Hilton J, Basketter DA, Kimber I. Cytokine endpoints for the local lymph node essay: consideration of interferon-γ and interleukin 12. J. Appl. Toxicol. 1999; 19: 149-155.
37. Boehm KD, Yun JK, Strohl KP, Elmets C. Human epidermal cytokine transcript level changes in situ following urushiol application. J. Invest. Dermatol. 1992; 98: 571.
38. Barker JN, Jones ML, Swenson CL, Sarma V, Mitra RS, Ward PA, Johnson KJ, Fantone JK, Dixit VM, Nickoloff BJ. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J. Immunol. 1991; 146: 1192-1197.
39. Piguet PF, Grau GE, Hauser C, Vassali P. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J. Exp. Med. 1991; 173: 673-679.
40. Griffiths CE, Barker JN, Kunkel S, Nickoloff BJ. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (Rhus dermatitis). Br. J. Dermatol. 1991; 124: 519-526.
41. Berg J, Leach MV, Kühn R, Rajewsky K, Müller W, Davidson NJ, Rennick D. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 1995; 182: 99-108.
42. Enk AH, Saloga J, Becker D et al. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 1994; 179: 1397-1402.
43. Ferguson TA, Dube P, Griffith TS. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 1994; 179: 1597-1604.
44. Schwarz T, Urbanski A, Luger TA. Ultraviolet light and epidermal cell derived cytokines. In Epidermal Growth Factors and Cytokines, Luger TA, Schwarz T (eds). Marcel Dekker: New York, 1994; 303-324.
45. Kondo S, McKenzie RC, Sauder DN. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J. Invest. Dermatol. 1994; 103: 811-814.
46. Asada H, Linton J, Katz SI. Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. J. Invest. Dermatol. 1997; 108: 406-411.
47. Webb EF, Tzimas MN, Newsholme SJ, Griswold DE. Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4. J. Invest. Dermatol. 1998; 111: 86-92.
48. Rowe A, Bunker CB. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis. Contact Dermatit. 1992; 38: 36-39.
49. Piguet PF. Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin. Semin. Immunopathol. 1992; 13: 345-354.
50. Xu B, Aojama K, Kitani A, Matsuyama T, Matsushita T. RT-PCR analysis of in vivo cytokine profiles in murine allergic contact dermatitis to DNCB. Toxicol. Meth. 1996; 1: 23-31.
51. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous border perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 1992; 90: 482-487.
52. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR. Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J. Invest. Dermatol. 1994; 103: 834-838.
53. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp. Dermatol. 1994; 3: 56-60.
54. Tsai JC, Feingold KR, Crumrine D, Wood LC, Grunfeld C, Elias PM. Permeability barrier disruption afters the localization and expression of TNF alpha-protein in the epidermis. Arch. Dermatol. Res. 1994; 286: 242-248.
55. Denda M, Emami S, Wood LC, Elias PM. Epidermal injury vs. barier disruption as initiators of epidermal proliferation and inflammation. J. Invest. Dermatol. 1995; 104: 562.
56. Ansel JC, Luger TA, Green I. The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes. J. Invest. Dermatol. 1983; 81: 519-523.
57. Kupper TS, McGuire J. Hydrocortisone reduces both constitutive and UV elicited release of epidermal thymocyto activating factor (ETAF) by cultured keratinocytes. J. Invest. Dermatol. 1986; 87: 570-573.
58. Kirnbauer R, Köck A, Neuner P, Förster E, Krutmann J, Urbanski A, Schauer E, Ansel JC, Schwarz T, Luger TA. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J. Invest. Dermatol. 1991; 96: 484-489.
59. Köck A, Urbanski A, Luger TA. mRNA expression and release of tumor necrosis factor by human epidermal cells. J. Invest. Dermatol. 1989; 92: 462.
60. Schwarz T, Luger TA. Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. 1989; B4: 1-13.
61. Aubin F, Kripke ML, Ullrich SE. Activation of keratinocytes with psoralen plus UVA radiation induces the release of soluble factors that suppress delayed and contact hypersensitivity. J. Invest. Dermatol. 1991; 97: 995-1000.
62. Schwarz T, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 1994; 103: 211-216.
63. Takashima A, Bergstresser PR. Impact of UVB radiation on the epidermal cytokine network. J. Photochem. Photobiol. 1996; 63: 397-400.
64. Norris DA, Lyons MB, Middleton MH, Yohn JJ, Kashihara-Sawami M. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) in the surface of cultured human keratinocytes. J. Invest. Dermatol. 1990; 95: 132-138.
65. Rivas JM, Ullrich SE. Essential role of keratinocyte-derived IL-10 in the UV-induced suppression of delayed type hypersensitivity but not contact hypersensitivity. J. Invest. Dermatol. 1993; 100: 522.
66. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J. Invest. Dermatol. 1995; 104: 3-6.
67. Yoshikawa T, Streilein JW. Genetic basis of the effects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenicity 1990; 32: 398-405.
68. Schmitt A, Owen-Schaub L, Ullrich SE. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. J. Immunol. 1995; 154: 5114-5120.
69. Riemann H, Schwarz A, Grabbe S, Aragane Y, Luger TA, Wysocka M, Kubin M, Trinchieri G, Schwarz T. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J. Immunol. 1996; 156: 1799-1803.
70. Mohamadzadeh M, Takashima A, Dougherty, Knop J, Begstresser PR, Cruz PD Jr. Ultraviolet B radiation up-regulates the expression of IL-15 in human skin. J. Immunol. 1995; 155: 4492-4496.
71. Kitajima T, Takashima A. Langerhans cell responses to ultraviolet B radiation. J. Dermatol. Sci. 1999; 19: 153-160.
72. Muller G, Knop J, Enk AH. Is cytokine expression responsible for differences between allergens and irritants? Am. J. Contact Dermatit. 1996; 3: 177-184.
73. Griswold DE, Connor JR, Dalton A, Lee JC, Simon P, Hillegass L, Sieg DJ, Hanna N. Activation of the IL-1 gene in UV-irradiated mouse skin: association with inflammatory sequelae and pharmacologic intervention. J. Invest. Dermatol. 1991; 97: 1019-1023.
74. Brand CU, Hunziker T, Yawalkar N, Braathen LR. IL-1 β protein in human skin lymph does not discriminate allergic from irritant contact dermatitis. Contact Dermatit. 1996; 35: 152-156.
75. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, Conn CA, Sozynski D, Grabiec C, Trumbauer ME, Shaw A. Resistance to fever induction and impaired acute-phase response in interleukin-1-β-deficient mice. Immunity 1995; 3: 9-19.
76. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 1995; 155: 4207-4217.
77. Kalish RS, Askenase PW. Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allerg. Clin. Immunol. 1999; 103: 192-199.
78. Koga T, Fujimura T, Imayama S, Katsuoka K, Toshitani S, Hory Y. The expression of Th1 and Th2 type cytokines in a lesion of allergic contact dermatitis. Contact Dermatit. 1996; 35: 105-106.
79. Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 1998; 19: 568-574.